In vivo and in vitro Antitumor effects of platycodin D, A saponin purified from platycodi radix on the H520 lung cancer cell

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Park, Jae Chan ^a   Lee, Young Joon ^a   Choi, Hae Yun ^a   Shin, Yong Kook ^b   Kim, Jong Dae ^a   Ku, Sae Kwang ^a  

^a Daegu Haany University   (South Korea)

^b Semyung University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYCLOOXYGENASE 2; GEMCITABINE; IMMUNOMODULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; PLATYCODIN D; SAPONIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CACHEXIA; CANCER CONTROL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER CELL LINE; MOUSE; MTT ASSAY; NONHUMAN; NUDE MOUSE; TUMOR VOLUME; XENOGRAFT;

EID: 84912137634     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/478653     Document Type: Article

References (74)

1. Jemal A.; Siegel R.; Xu J.; Ward E.; Cancer statistics, 2010. CA: A Cancer Journal for Clinicians 2010 60 5 277 300 10.3322/caac.20073 2-s2.0-77955635233
2. Tonon G.; Wong K.-K.; Maulik G.; Brennan C.; Feng B.; Zhang Y.; Khatry D. B.; Protopopov A.; You M. J.; Aguirre A. J.; Martin E. S.; Yang Z.; Ji H.; Chin L.; DePinho R. A.; High-resolution genomic profiles of human lung cancer. Proceedings of the National Academy of Sciences of the United States of America 2005 102 27 9625 9630 10.1073/pnas.0504126102 2-s2.0-22144433675
3. Sher T.; Dy G. K.; Adjei A. A.; Small cell lung cancer. Mayo Clinic Proceedings 2008 83 3 355 367 2-s2.0-41549084663 10.4065/83.3.355
4. Maziak D. E.; Markman B. R.; MacKay J. A.; Evans W. K.; Photodynamic therapy in nonsmall cell lung cancer: a systematic review. The Annals of Thoracic Surgery 2004 77 4 1484 1491 10.1016/j.athoracsur.2003.07.017 2-s2.0-1842531487
5. Ferreira C. G.; Huisman C.; Giaccone G.; Novel approaches to the treatment of non-small cell lung cancer. Critical Reviews in Oncology/Hematology 2002 41 1 57 77 10.1016/S1040-8428(01)00197-4 2-s2.0-0036143667
6. Yang P.; Allen M. S.; Aubry M. C.; Wampfler J. A.; Marks R. S.; Edell E. S.; Thibodeau S.; Adjei A. A.; Jett J.; Deschamps C.; Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005 128 1 452 462 10.1378/chest.128.1.452 2-s2.0-22244480031
7. Hoffman P. C.; Mauer A. M.; Vokes E. E.; Lung cancer. The Lancet 2000 355 9202 479 485 10.1016/S0140-6736(00)82038-3 2-s2.0-0034606998
8. Laviano A.; Meguid M. M.; Inui A.; Muscaritoli M.; Rossi-Fanelli F.; Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself. Nature Clinical Practice Oncology 2005 2 3 158 165 10.1038/ncponc0112 2-s2.0-20144377885
9. Evans W. J.; Morley J. E.; Argilés J.; Cachexia: a new definition. Clinical Nutrition 2008 27 6 793 799 10.1016/j.clnu.2008.06.013 2-s2.0-55749085001
10. Gullett N.; Rossi P.; Kucuk O.; Johnstone P. A. S.; Cancer-induced cachexia: a guide for the oncologist. Journal of the Society for Integrative Oncology 2009 7 4 155 169 10.2310/7200.2009.0018 2-s2.0-76649098527
11. Weyermann P.; Dallmann R.; Magyar J.; Anklin C.; Hufschmid M.; Dubach-Powell J.; Courdier-Fruh I.; Henneböhle M.; Nordhoff S.; Mondadori C.; Orally available selective melanocortin-4 receptor antagonists stimulate food intake and reduce cancer-induced cachexia in mice. PLoS ONE 2009 4 3 e4774 10.1371/journal.pone.0004774 2-s2.0-63349100316
12. Finke J.; Ferrone S.; Frey A.; Mufson A.; Ochoa A.; Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunology Today 1999 20 4 158 160 10.1016/S0167-5699(98)01435-2 2-s2.0-0032947187
13. Pawelec G.; Heinzel S.; Kiessling R.; Muller L.; Ouyang Q.; Zeuthen J.; Escape mechanisms in tumor immunity: a year 2000 update. Critical Reviews in Oncogenesis 2000 11 2 97 133 2-s2.0-0033833503
14. Ha E. S.; Hwang S. H.; Shin K.-S.; Anti-metastatic activity of glycoprotein fractionated from Acanthopanax senticosus, involvement of NK-cell and macrophage activation. Archives of Pharmacal Research 2004 27 2 217 224 10.1007/BF02980109 2-s2.0-4644342494
15. Yoo K. M.; Hwang I. K.; In vitro effect of Yuza (Citrus junos SIEB ex TANAKA) extracts on proliferation of human prostate cancer cells and antioxidant activity. Korean Journal of Food Science and Technology 2004 36 2 339 344
16. Ham Y.-A.; Choi H.-J.; Kim S.-H.; Chung M.-J.; Ham S.-S.; Antimutagenic and antitumor effects of Adenophora triphylla extracts. Journal of the Korean Society of Food Science and Nutrition 2009 38 1 25 31 2-s2.0-66549100907 10.3746/jkfn.2009.38.1.025
17. Han L.-K.; Xu B.-J.; Kimura Y.; Zheng Y.-N.; Okuda H.; Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity. The Journal of Nutrition 2000 130 11 2760 2764 2-s2.0-0033735626
18. Han L.-K.; Zheng Y.-N.; Xu B.-J.; Okuda H.; Kimura Y.; Saponins from Platycodi radix ameliorate high fat diet-induced obesity in mice. Journal of Nutrition 2002 132 8 2241 2245 2-s2.0-0036322011
19. Zhao H. L.; Sim J.-S.; Shim S. H.; Ha Y. W.; Kang S. S.; Kim Y. S.; Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction. International Journal of Obesity 2005 29 8 983 990 10.1038/sj.ijo.0802948 2-s2.0-23044468331
20. Hong J. J.; Shin K. H.; Lim S. S.; Kwak J. H.; Zee O. P.; Ishihara K.; Hirasawa N.; Seyama T.; Ohuchi K.; Lead compounds for anti-inflammatory drugs isolated from the plants of the traditional oriental medicine in Korea. Inflammation and Allergy-Drug Targets 2008 7 3 195 202 2-s2.0-55249113681 10.2174/187152808785748100
21. Choi S.-S.; Han E.-J.; Lee T.-H.; Han K.-J.; Lee H.-K.; Suh H.-W.; Antinociceptive profiles of platycodin D in the mouse. The American Journal of Chinese Medicine 2004 32 2 257 268 10.1142/S0192415X04001916 2-s2.0-3543006031
22. Xie Y.; Sun H.-X.; Li D.; Platycodin D improves the immunogenicity of newcastle disease virus-based recombinant avian influenza vaccine in mice. Chemistry and Biodiversity 2010 7 3 677 689 10.1002/cbdv.200900183 2-s2.0-77949711408
23. Dai Q.; Chen Z.; Ge Y.-Q.; Liu P.; Wang H.-B.; Ma X.-Q.; Wu B.-H.; Mechanism of platycodin D-induced humane long cancer cells A549 apoptosis. Zhongguo Zhongyao Zazhi 2012 37 17 2626 2629 2-s2.0-84870207279 10.4268/cjcmm20121725
24. Kim Y. S.; Kim J. S.; Choi S.-U.; Lee H. S.; Roh S. H.; Jeong Y. C.; Kim Y.-K.; Ryu S. Y.; Isolation of a new saponin and cytotoxic effect of saponins from the root of Platycodon grandiflorum on human tumor cell lines. Planta Medica 2005 71 6 566 568 10.1055/s-2005-864161 2-s2.0-21344449760
25. Hennig R.; Ventura J.; Segersvard R.; Ward E.; Ding X.-Z.; Rao S. M.; Jovanovic B. D.; Iwamura T.; Talamonti M. S.; Bell R. H. Jr.; Adrian T. E.; LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. Neoplasia 2005 7 4 417 425 10.1593/neo.04559 2-s2.0-20844460134
26. Wang H.; Rayburn E. R.; Wang W.; Kandimalla E. R.; Agrawal S.; Zhang R.; Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy. Molecular Cancer Therapeutics 2006 5 8 2106 2114 2-s2.0-33748457159 10.1158/1535-7163.MCT-06-0158
27. Kim K.-S.; Seo E.-K.; Lee Y.-C.; Effect of dietary Platycodon grandiflorum on the improvement of insulin resistance in obese Zucker rats. The Journal of Nutritional Biochemistry 2000 11 9 420 424 10.1016/S0955-2863(00)00098-X 2-s2.0-0033696628
28. Kim Y. P.; Lee E. B.; Kim S. Y.; Li D.; Ban H. S.; Lim S. S.; Shi K. H.; Ohuchi K.; Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum. Planta Medica 2001 67 4 362 364 10.1055/s-2001-14317 2-s2.0-0034743436
29. Nishimura G.; Yanoma S.; Mizuno H.; Kawakami K.; Tsukuda M.; An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells. Japanese Journal of Cancer Research 1999 90 11 1224 1230 10.1111/j.1349-7006.1999.tb00700.x 2-s2.0-0032761948
30. Iizuka N.; Miyamoto K.; Hazama S.; Yoshino S.; Yoshimura K.; Okita K.; Fukumoto T.; Yamamoto S.; Tangoku A.; Oka M.; Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Letters 2000 158 1 35 41 10.1016/S0304-3835(00)00496-1 2-s2.0-0034730953
31. Hubbell H. R.; Kvalnes-Krick K.; Carter W. A.; Strayer D. R.; Antiproliferative and immunomodulatory actions of β -interferon and double-stranded RNA, individually and in combination, on human bladder tumor xenografts in nude mice. Cancer Research 1985 45 6 2481 2486 2-s2.0-0021882132
32. Yoon H. S.; Kim J. W.; Cho H. R.; Moon S. B.; Shin H. D.; Yang K. J.; Lee H. S.; Kwon Y. S.; Ku S. K.; Immunomodulatory effects of Aureobasidium pullulans SM-2001 exopolymers on the cyclophosphamide-treated mice. Journal of microbiology and biotechnology 2010 20 2 438 445 2-s2.0-77953462916
33. Clark B. D.; Bedrosian I.; Schindler R.; Cominelli F.; Cannon J. G.; Shaw A. R.; Dinarello C. A.; Detection of interleukin 1 and 1 β in rabbit tissues during endotoxemia using sensitive radioimmunoassays. Journal of Applied Physiology 1991 71 6 2412 2418 2-s2.0-0026344218
34. Jung Y.-M.; Lee S.-H.; Lee D.-S.; You M.-J.; Chung I. K.; Cheon W. H.; Kwon Y.-S.; Lee Y.-J.; Ku S.-K.; Fermented garlic protects diabetic, obese mice when fed a high-fat diet by antioxidant effects. Nutrition Research 2011 31 5 387 396 10.1016/j.nutres.2011.04.005 2-s2.0-79957696834
35. Shi S.-R.; Chaiwun B.; Young L.; Cote R. J.; Taylor C. R.; Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. Journal of Histochemistry and Cytochemistry 1993 41 11 1599 1604 10.1177/41.11.7691930 2-s2.0-0027484586
36. Kim T.-H.; Hur E.-G.; Kang S.-J.; Kim J.-A.; Thapa D.; Mie Lee Y.; Ku S. K.; Jung Y.; Kwak M.-K.; NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1 Cancer Research 2011 71 6 2260 2275 2-s2.0-79952749190 10.1158/0008-5472.CAN-10-3007
37. Shin D.-H.; Park H.-M.; Jung K.-A.; Choi H.-G.; Kim J.-A.; Kim D.-D.; Kim S. G.; Kang K. W.; Ku S. K.; Kensler T. W.; Kwak M.-K.; The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. Free Radical Biology and Medicine 2010 48 8 1051 1063 2-s2.0-77950517594 10.1016/j.freeradbiomed.2010.01.021
38. Schiller J. H.; Harrington D.; Belani C. P.; Langer C.; Sandler A.; Krook J.; Zhu J.; Johnson D. H.; Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. The New England Journal of Medicine 2002 346 2 92 98 10.1056/NEJMoa011954 2-s2.0-0037050352
39. Natale R.; A ten-year review of progress in the treatment of non-small-cell lung cancer with gemcitabine. Lung Cancer 2005 50 supplement 1 S2 S4 10.1016/S0169-5002(05)81549-1 2-s2.0-27744548299
40. Visbal A. L.; Leighl N. B.; Feld R.; Shepherd F. A.; Adjuvant chemotherapy for early-stage non-small cell lung cancer. Chest 2005 128 4 2933 2943 2-s2.0-27144438521 10.1378/chest.128.4.2933
41. Silvestri G. A.; Rivera M. P.; Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists. Chest 2005 128 6 3975 3984 10.1378/chest.128.6.3975 2-s2.0-30344446398
42. Han S.-Y.; Zhao M.-B.; Zhuang G.-B.; Li P.-P.; Marsdenia tenacissima extract restored gefitinib sensitivity in resistant non-small cell lung cancer cells. Lung Cancer 2012 75 1 30 37 10.1016/j.lungcan.2011.06.001 2-s2.0-83555173427
43. Shord S. S.; Patel S. R.; Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines. Journal of Experimental and Clinical Cancer Research 2009 28 1, article 76 10.1186/1756-9966-28-76 2-s2.0-68149098691
44. Clark J. C. M.; Dass C. R.; Choong P. F. M.; Development of chondrosarcoma animal models for assessment of adjuvant therapy. ANZ Journal of Surgery 2009 79 5 327 336 10.1111/j.1445-2197.2009.04884.x 2-s2.0-67650859912
45. Kim S.; Animal models of cancer in the head and neck region. Clinical and Experimental Otorhinolaryngology 2009 2 2 55 60 10.3342/ceo.2009.2.2.55 2-s2.0-67651232299
46. Holmstrom A.; Wu R. T. Y.; Zeng H.; Lei K. Y.; Cheng W.-H.; Nutritional and supranutritional levels of selenate differentially suppress prostate tumor growth in adult but not young nude mice. The Journal of Nutritional Biochemistry 2012 23 9 1086 1091 10.1016/j.jnutbio.2011.06.001 2-s2.0-84865067162
47. Kennedy J. D.; Pierce C. W.; Lake J. P.; Extrathymic T cell maturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. Journal of Immunology 1992 148 6 1620 1629 2-s2.0-0026572736
48. Lee J.-Y.; Lee Y.-M.; Chang G.-C.; Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. PLoS ONE 2011 6 8 e23756 10.1371/journal.pone.0023756 2-s2.0-80051746642
49. Liu L.; Jiang Z.; Teng G.-J.; Song J.-Z.; Zhang D.-S.; Guo Q.-M.; Fang W.; He S.-C.; Guo J.-H.; Clinical and experimental study on regional administration of phosphorus-32 glass microspheres in treating hepatic carcinoma. World Journal of Gastroenterology 1999 5 6 492 505 2-s2.0-0000377097
50. Matés J. M.; Segura J. A.; Alonso F. J.; Márquez J.; Anticancer antioxidant regulatory functions of phytochemicals. Current Medicinal Chemistry 2011 18 15 2315 2338 10.2174/092986711795656036 2-s2.0-79957955458
51. Tsubura A.; Lai Y.-C.; Kuwata M.; Uehara N.; Yoshizawa K.; Anticancer effects of garlic and garlic-derived compounds for breast cancer control. Anti-Cancer Agents in Medicinal Chemistry 2011 11 3 249 253 10.2174/187152011795347441 2-s2.0-79954500271
52. Sakai H.; Kokura S.; Ishikawa T.; Tsuchiya R.; Okajima M.; Matsuyama T.; Adachi S.; Katada K.; Kamada K.; Uchiyama K.; Handa O.; Takagi T.; Yagi N.; Naito Y.; Yoshikawa T.; Effects of anticancer agents on cell viability, proliferative activity and cytokine production of peripheral blood mononuclear cells. Journal of Clinical Biochemistry and Nutrition 2013 52 1 64 71 10.3164/jcbn.12-60 2-s2.0-84872354127
53. Suzuki E.; Sun J.; Kapoor V.; Jassar A. S.; Albelda S. M.; Gemcitabine has significant immunomodulatory activity in murine tumor models independent of its cytotoxic effects. Cancer Biology and Therapy 2007 6 6 880 885 10.4161/cbt.6.6.4090 2-s2.0-38549148416
54. Samira S.; Ferrand C.; Peled A.; Nagler A.; Tovbin Y.; Ben-Hur H.; Taylor N.; Globerson A.; Lapidot T.; Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice. Stem Cells 2004 22 6 1085 1100 10.1634/stemcells.22-6-1085 2-s2.0-8644290208
55. Isaacs A.; Tizard I. R.; Lymphokines and cytokines. Immunology: An Introduction 1995 Philadelphia, Pa, USA Saunders 155 169
56. Unanue E. R.; Tizard I. R.; The mononuclear-phagocytic sytem. Immunology: An Introduction 1995 Philadelphia, Pa, USA Saunders 61 74
57. Nuñez G.; Benedict M. A.; Hu Y.; Inohara N.; Caspases: the proteases of the apoptotic pathway. Oncogene 1998 17 25 3237 3245 2-s2.0-0344389027
58. Barrett K. L.; Willingham J. M.; Garvin A. J.; Willingham M. C.; Advances in cytochemical methods for detection of apoptosis. The Journal of Histochemistry and Cytochemistry 2001 49 7 821 832 10.1177/002215540104900703 2-s2.0-0034967854
59. Trucco C.; Oliver F. J.; de Murcia G.; Ménissier-de Murcia J.; DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids Research 1998 26 11 2644 2649 10.1093/nar/26.11.2644 2-s2.0-0032102896
60. Smulson M. E.; Pang D.; Jung M.; Dimtchev A.; Chasovskikh S.; Spoonde A.; Simbulan-Rosenthal C.; Rosenthal D.; Yakovlev A.; Dritschilo A.; Irreversible binding of poly(ADP)ribose polymerase cleavage product to DNA ends revealed by atomic force microscopy: possible role in apoptosis. Cancer Research 1998 58 16 3495 3498 2-s2.0-0032529636
61. Smyth P. G.; Berman S. A.; Bursztajn S.; Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system. BioTechniques 2002 32 3 648 665 2-s2.0-0036189914
62. Fang E. F.; Zhang C. Z. Y.; Zhang L.; Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis. PLoS ONE 2012 7 9 e41592 2-s2.0-84866050965 10.1371/journal.pone.0041592
63. Qin Y.; Sun C. Y.; Lu F. R.; Shu X. R.; Yang D.; Chen L.; She X. M.; Gregg N. M.; Guo T.; Hu Y.; Cardamonin exerts potent activity against multiple myeloma through blockade of NF- B pathway in vitro. Leukemia Research 2012 36 4 514 520 10.1016/j.leukres.2011.11.014 2-s2.0-84857236804
64. Chell S.; Kadi A.; Caroline Williams A.; Paraskeva C.; Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Biochimica et Biophysica Acta 2006 1766 1 104 119 10.1016/j.bbcan.2006.05.002 2-s2.0-33747028253
65. Southan G. J.; Szabó C.; Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochemical Pharmacology 1996 51 4 383 394 10.1016/0006-2952(95)02099-3 2-s2.0-0030040255
66. Kostourou V.; Cartwright J. E.; Johnstone A. P.; Boult J. K. R.; Cullis E. R.; Whitley G.; Robinson S. P.; The role of tumour-derived iNOS in tumour progression and angiogenesis. British Journal of Cancer 2011 104 1 83 90 10.1038/sj.bjc.6606034 2-s2.0-78650897830
67. Xie K.; Huang S.; Dong Z.; Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. The Journal of Experimental Medicine 1995 181 4 1333 1343 10.1084/jem.181.4.1333 2-s2.0-0028929559
68. Yan J.; Wang Q.; Zheng X.; Sun H.; Zhou Y.; Li D.; Lin Y.; Wang X.; Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model. Biochemical and Biophysical Research Communications 2012 417 2 842 846 10.1016/j.bbrc.2011.12.055 2-s2.0-84855836595
69. Inui A.; Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Research 1999 59 18 4493 4501 2-s2.0-0033567912
70. Tisdale M. J.; Biology of cachexia. Journal of the National Cancer Institute 1997 89 23 1763 1773 2-s2.0-0030665384 10.1093/jnci/89.23.1763
71. Fujita J.; Tsujinaka T.; Yano M.; Anti-interleukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways. International Journal of Cancer 1996 68 5 637 643
72. Kurebayashi J.; Yamamoto S.; Otsuki T.; Sonoo H.; Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect. British Journal of Cancer 1999 79 3-4 631 636 10.1038/sj.bjc.6690099 2-s2.0-0032960563
73. Strassmann G.; Fong M.; Kenney J. S.; Jacob C. O.; Evidence for the involvement of interleukin 6 in experimental cancer cachexia. Journal of Clinical Investigation 1992 89 5 1681 1684 10.1172/JCI115767 2-s2.0-0026689535
74. Oka M.; Yamamoto K.; Takahashi M.; Hakozaki M.; Abe T.; Iizuka N.; Hazama S.; Hirazawa K.; Hayashi H.; Tangoku A.; Hirose K.; Ishihara T.; Suzuki T.; Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Research 1996 56 12 2776 2780 2-s2.0-9344266888